P&G’s Implied Superiority Claim For Olay Vs. Dove Is Unsupported – NAD
This article was originally published in The Rose Sheet
P&G/Olay comes away from a National Advertising Division dispute at liberty to use in future ads, at best, a qualified version of the least assertive claim it ran in print and online for Olay Ultra Moisture bar soap. According to challenger Unilever, the Cincinnati firm’s advertising, when considered in its totality, communicated the unsubstantiated message that P&G’s offering is superior to the Dove white bar.
You may also be interested in...
Farah Ahmed, president and CEO of the Fragrance Creators Association, discusses the trade group’s expansion in recent years beyond immediate regulatory and legislative concerns to a platform for robust member collaboration in the name of positively impacting the world.
Cannabidiol (CBD) represents an intriguing opportunity for cosmetics, without the statutory obstacles faced by food and dietary supplement companies. Cosmetics marketers are taking advantage, but the FDA’s recent warning letter blitz is a reminder that CBD-infused beauty products are bound by the same rules that apply to other cosmetics.
Federal preemption of state and local requirements that differ from federal mandates came up repeatedly at the House Energy & Commerce Health Subcommittee’s 4 December cosmetics hearing. Meanwhile, both NGO and industry stakeholders generally support FDA review of cosmetic ingredients, but the details of such a framework likely will be contentious as work progresses.